Amylose chiral separations

Aboul-Enein and Ali [78] compared the chiral resolution of miconazole and two other azole compounds by high performance liquid chromatography using normal-phase amylose chiral stationary phases. The resolution of the enantiomers of ( )-econazole, ( )-miconazole, and (i)-sulconazole was achieved on different normal-phase chiral amylose columns, Chiralpak AD, AS, and AR. The mobile phase used was hexane-isopropanol-diethylamine (400 99 1). The flow rates of the mobile phase used were 0.50 and 1 mL/min. The separation factor (a) values for the resolved enantiomers of econazole, miconazole, and sulconazole in the chiral phases were in the range 1.63-1.04 the resolution factors Rs values varied from 5.68 to 0.32. 

Amylose inclusion compounds, 14 168 Amylosic phases, for chiral separations, 6 88-89... 

In sub-FC, a detailed study of the influence of mobile phase additives on the chiral resolution of isoxazoline-based Ilb/IIIb receptor antagonists was carried out by Blackwell [145] on Chiralcel OD-H CSPs. The different mobile phase additives used were acetic acid, trifluoroacetic acid, formic acid, water, triethylamine, triethanolamine, n-hexylamine, trimethyl phosphate, and tri-w-butyl phosphate. In general, n-hexylamine and tri-/ -butyl phosphate mobile phase additives resulted in better resolution. The chiral separation of four 1,3-dioxolane derivatives on an amylose-based column has been described [151]. The effects of mobile phase composition, temperature, and pressure have been investigated. The nature of the modifier is the main parameter it has the highest impact on chiral resolution and is more important than the polarity of the mobile phase. Therefore, the organic modifier that gave the best enantiomeric separation was different for each compound. 

The inherent chiral nature and availability of natural polymers, such as cellulose and amylose, were the primary reasons of their use in chiral separations. The ability of cellulose to separate racemic mixtures was first observed in paper chromatography [76,77]. The breakthrough point in the use of cellulose and amylose in modern HPLC was achieved with the development of CSPs where saccharides were adsorbed on the surface of aminopropyl-modified macroporous silica, [78,79]. 

To address development of chiral separations by SFC, Villeneuve and Anderegg have developed an SFC system using automated modifier and column selection valves. Columns (250 x 4.6 mm i.d., 10 pm) packed with Chiralpak AD, Chiralpak AS amylose derivative, Chiralcel OD cellulose carbamate derivative, and Chiralcel OJ cellulose ester derivative (Chiral Techologies, Exton, PA) were connected to a column-switching valve. Candidate samples were run successively on each column using fixed isocratic, isobaric, and isothermal conditions of 2 ml/min, 205 atm pressure, and 40 °C with the vari-... 

In practice, it has been found that certain derivatives e.g. tris (3,5-dimethylphenyl carbamate) render the coating less culnerable to solvent dissolution. As a consequence this stationary phase can be used with buffered methanol/water or acetonitrile/water with certain care being taken. Therefore, the tris(3,5-dimethylphenyl carbamate) derivatives of both cellulose and amylose can, with caution, be used in the reversed phase mode. As example of a chiral separation using the different modes is shown in figure 8.6. 

Native molecules are not used frequently for chiral separations because of the dense structure of the oligo- and polysaccharide chains (of which some are helical). Polysaccharides are often derivatized to increase their enantioselec-tivity by enlarging their cavities. This structural change is important because the cavities contribute to the enantiose-lectivity by inclusion of the compounds. Enantiomers are thus separated based on their different affinities (hydrogen bonds, dipole-, tt-tt-, and van der Waals interactions) for the chiral cavities of the saccharides. In Figure 52.11, the structures of amylose, dextran, and heparin, a few polysaccharide selectors, are shown. 

It is worth mentioning that natural products, due to their enantiopurity, play an important technical function in the development of suitable methods for chiral separations. Cellulose and amylose, which are easily accessible chiral polymers, after derivatization, are used as chiral stationary phases for both HPLC and TLC [29-31]. Microbial degradation of starch yielded CDs, -CD-bonded silica gel provide the most popular chiral stationary phases. 

As mentioned previously, cellulosic phases as well as amylosic phases have also been used extensively for enantiomeric separations more recently (89,90). Most of the work ia this area has been with various derivatives of the native carbohydrate. The enantioresolving abiUties of the derivatized cellulosic and amylosic phases are reported to be very dependent on the types of substituents on the aromatic moieties that are appended onto the native carbohydrate (91). Table 3 fists some of the cellulosic and amylosic derivatives that have been used. These columns are available through Chiral Technologies, Inc. and J. T. Baker, Inc. 

An hplc assay was developed suitable for the analysis of enantiomers of ketoprofen (KT), a 2-arylpropionic acid nonsteroidal antiinflammatory dmg (NSAID), in plasma and urine (59). Following the addition of racemic fenprofen as internal standard (IS), plasma containing the KT enantiomers and IS was extracted by Hquid-Hquid extraction at an acidic pH. After evaporation of the organic layer, the dmg and IS were reconstituted in the mobile phase and injected onto the hplc column. The enantiomers were separated at ambient temperature on a commercially available 250 x 4.6 mm amylose carbamate-packed chiral column (chiral AD) with hexane—isopropyl alcohol—trifluoroacetic acid (80 19.9 0.1) as the mobile phase pumped at 1.0 mL/min. The enantiomers of KT were quantified by uv detection with the wavelength set at 254 nm. The assay allows direct quantitation of KT enantiomers in clinical studies in human plasma and urine after adrninistration of therapeutic doses. 

Examples with other Pirkle-type CSPs have also been described [139, 140]. In relation to polysaccharides coated onto silica gel, they have shown long-term stability in this operation mode [141, 142], and thus are also potentially good chiral selectors for preparative SFC [21]. In that context, the separation of racemic gliben-clamide analogues (7, Fig. 1-3) on cellulose- and amylose-derived CSPs was described [143]. 

Ferretti et al. (1988) used an amino column coupled to a derivatized amylose column (Chiralpak AS) operated in the reverse-phase mode to separate the enantiomers of the antifungal agent voriconazole from several chiral impurities and one achiral impurity. Three of the chiral impurities are the other enantiomer and corresponding diastereomers of voriconazole. More chiral impurities result from a chlorinated voriconazole. Additionally, this multidimensional method could baseline separate all but two of the chiral impurities into their respective enantiomers. These separations are shown in Figure 14.5. 

The enantiomers of many compounds are eluted in reverse order on the 3,5-dimethylphenylcarbamates of cellulose (23x) and amylose (24n), suggesting that these two CSPs may be complementary in recognizing chirality. Many enantiomers unresolved on 23x can be resolved on 24n, and vice versa. Consequently, when two 23x and 24n columns were used for the resolution of 500 racemates, nearly 80% of the racemates were separated into enantiomers at least on either of 23x and 24n. 

Musshoff et al. [35] developed a method for the enantiomeric separation of the synthetic opioid agonist tramadol and its desmethyl metabolite using a Chiralpak AD column containing amylose tris-(3,5-dimethylphenylcarbamate) as chiral selector and a n-hexane/ethanol, 97 3 v/v (5mM TEA) mobile phase nnder isocratic conditions (1 mL/min). After atmospheric pressure chemical ionization (APCI), detection was carried out in positive-ion MS-MS SRM mode. The method allowed the confirmation of diagnosis of overdose or intoxication as well as monitoring of patients compliance. 

---